Concepedia

John Silowsky

JS

1

Publications

13

Citations

1

H-Index

2020

Active since

Affiliations

Caelum Research Corporation (United States)(Current)

John Silowsky is an author at Caelum Research Corporation (United States).

Publications per year

2020–2020

1

Publications

1

Cael-101 Is Well-Tolerated in AL Amyloidosis Patients Receiving Concomitant Cyclophosphamide-Bortezomib-Dexamethasone (CyborD): A Phase 2 Dose-Finding Study (NCT04304144)

Jason Valent, John Silowsky, Michael R. Kurman et al. · Blood · 2020 · 13 citations

Rows per page

1–1 of 1